139 related articles for article (PubMed ID: 23061759)
1. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.
El Atrache MM; Abouljoud MS; Divine G; Yoshida A; Kim DY; Kazimi MM; Moonka D; Huang MA; Brown K
Clin Transplant; 2012; 26(5):E505-12. PubMed ID: 23061759
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
3. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
4. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
5. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
6. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up.
Álamo JM; Bernal C; Barrera L; Marín LM; Suárez G; Serrano J; Gómez MA; Padillo FJ
Transplant Proc; 2011; 43(6):2230-2. PubMed ID: 21839241
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
[TBL] [Abstract][Full Text] [Related]
10. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
[TBL] [Abstract][Full Text] [Related]
11. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis.
Saab S; Niho H; Comulada S; Hiatt J; Durazo F; Han S; Farmer DG; Holt C; Yersiz H; Goldstein LI; Ghobrial RM; Busuttil RW
Liver Int; 2005 Oct; 25(5):940-5. PubMed ID: 16162150
[TBL] [Abstract][Full Text] [Related]
12. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
[TBL] [Abstract][Full Text] [Related]
13. NAFLD recurrence in liver transplant recipients.
Dureja P; Mellinger J; Agni R; Chang F; Avey G; Lucey M; Said A
Transplantation; 2011 Mar; 91(6):684-9. PubMed ID: 21248661
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
15. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
Seyam M; Neuberger JM; Gunson BK; Hübscher SG
Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome.
Marmur J; Bergquist A; Stål P
Scand J Gastroenterol; 2010; 45(1):60-9. PubMed ID: 20030578
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.
Amarapurkar DN; Patel ND
Trop Gastroenterol; 2004; 25(3):125-9. PubMed ID: 15682659
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
